These findings underscore the importance of t(4;14) translocation, TP53 mutation, ISS staging, and serum amylase levels as key factors associated with PVR expression, offering potential markers for prognosis and disease progression in multiple myeloma. This evidence concerns the gene TP53 and AL amyloidosis.